{"filing":{"accession_number":"0001731122-26-001294","cik":"0001314052","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-24","primary_document":"e7977_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001294/e7977_8-k.htm"},"events":[{"id":35517,"run_id":32716,"accession_number":"0001731122-26-001294","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Anavex held its 2026 Annual Meeting on September 24, 2026, where shareholders voted on the election of six directors and ratification of Grant Thornton LLP as independent auditor. The Company's slate of director nominees defeated a contested slate of six PVG-nominated candidates, with detailed voting tallies certified by the Inspector of Elections.","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39593,"accession_number":"0001731122-26-001294","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the Company's Annual Meeting held on September 24, 2026. The Inspector's final vote tabulation certified results for two proposals: (1) election of six Company-nominated directors (defeating a contested slate of six PVG-nominated director candidates), and (2) ratification of Grant Thornton LLP as independent auditor. The detailed voting tallies for each nominee and proposal are provided, making this a textbook Item 5.07 shareholder_vote_results disclosure. The contested nature of the election and the substantial opposition votes (e.g., Jiong Ma received 14.3M against votes) make this material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:31:24.757212+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":35518,"run_id":32716,"accession_number":"0001731122-26-001294","anchor_item_number":"5.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The election of new directors at the 2026 Annual Meeting caused Incumbent Directors to fall below a majority, triggering a change-of-control event under the Company's Incentive Plans and employment agreements. This Board Change CIC immediately vested all outstanding equity awards and constitutes a material change in control affecting the registrant's governance and contractual obligations.","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39592,"accession_number":"0001731122-26-001294","item_number":"5.01","item_title":"Changes in Control of Registrant.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a \"change in control\" under the company's Incentive Plans and employment agreements triggered by a Board Change CIC at the 2026 Annual Meeting. Although no traditional M\u0026A transaction occurred, the election of new directors in a contested proxy contest caused Incumbent Directors to fall below a majority, triggering change-of-control provisions that immediately vested all outstanding equity awards. This constitutes a material change in control event affecting the registrant's governance and triggering contractual obligations, warranting classification as ma_activity rather than a routine governance matter.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:31:24.757212+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39592,"accession_number":"0001731122-26-001294","item_number":"5.01","item_title":"Changes in Control of Registrant.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a \"change in control\" under the company's Incentive Plans and employment agreements triggered by a Board Change CIC at the 2026 Annual Meeting. Although no traditional M\u0026A transaction occurred, the election of new directors in a contested proxy contest caused Incumbent Directors to fall below a majority, triggering change-of-control provisions that immediately vested all outstanding equity awards. This constitutes a material change in control event affecting the registrant's governance and triggering contractual obligations, warranting classification as ma_activity rather than a routine governance matter.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:31:24.757212+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-28"},{"id":39593,"accession_number":"0001731122-26-001294","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the Company's Annual Meeting held on September 24, 2026. The Inspector's final vote tabulation certified results for two proposals: (1) election of six Company-nominated directors (defeating a contested slate of six PVG-nominated director candidates), and (2) ratification of Grant Thornton LLP as independent auditor. The detailed voting tallies for each nominee and proposal are provided, making this a textbook Item 5.07 shareholder_vote_results disclosure. The contested nature of the election and the substantial opposition votes (e.g., Jiong Ma received 14.3M against votes) make this material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:31:24.757212+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-28"}]}